Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Do beta-tubulin pseudogenes really matter?
Belda-Iniesta C, Perona R, de Castro Carpeno J, Chattopadhyay S, Casado E, Cejas P, Fresno Vara JA, Moreno Guerra C, Gonzalez Baron M. Belda-Iniesta C, et al. Among authors: perona r. Lancet Oncol. 2004 May;5(5):271-2. doi: 10.1016/S1470-2045(04)01464-0. Lancet Oncol. 2004. PMID: 15120663 No abstract available.
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S, Machado-Pinilla R, Manguan-García C, Belda-Iniesta C, Moratilla C, Cejas P, Fresno-Vara JA, de Castro-Carpeño J, Casado E, Nistal M, Gonzalez-Barón M, Perona R. Chattopadhyay S, et al. Among authors: perona r. Oncogene. 2006 Jun 1;25(23):3335-45. doi: 10.1038/sj.onc.1209364. Epub 2006 Feb 6. Oncogene. 2006. PMID: 16462770
Molecular biology of malignant gliomas.
Belda-Iniesta C, de Castro Carpeño J, Casado Sáenz E, Cejas Guerrero P, Perona R, González Barón M. Belda-Iniesta C, et al. Among authors: perona r. Clin Transl Oncol. 2006 Sep;8(9):635-41. doi: 10.1007/s12094-006-0033-9. Clin Transl Oncol. 2006. PMID: 17005465 Review.
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R. Ibanez de Caceres I, et al. Among authors: perona r. Oncogene. 2010 Mar 18;29(11):1681-90. doi: 10.1038/onc.2009.454. Epub 2009 Dec 21. Oncogene. 2010. PMID: 20023704
MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M, Chattopadhyay S, Rovira A, Rodriguez-Fanjul V, Belda-Iniesta C, Tapia M, Cejas P, Machado-Pinilla R, Manguan-García C, Sánchez-Pérez I, Nistal M, Moratilla C, de Castro-Carpeño J, Gonzalez-Barón M, Albanell J, Perona R. Cortes-Sempere M, et al. Among authors: perona r. Cancer Lett. 2009 Dec 28;286(2):206-16. doi: 10.1016/j.canlet.2009.05.029. Epub 2009 Jun 23. Cancer Lett. 2009. PMID: 19553005
Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain).
Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, García-Cabezas MA, Vara JA, Domínguez-Cáceres A, Perona R, González-Barón M. Cejas P, et al. Among authors: perona r. Cancer Causes Control. 2004 Sep;15(7):707-19. doi: 10.1023/B:CACO.0000036189.61607.52. Cancer Causes Control. 2004. PMID: 15280629 Review.
130 results